Skip to main content
Carol Shields, MD, Ophthalmology, Philadelphia, PA

CarolLShieldsMD

Ophthalmology Philadelphia, PA

Pediatric & Strabismus, Retinal Disease, Ocular Oncology

Professor of Ophthalmology, Thomas Jefferson University

Dr. Shields is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Shields' full profile

Already have an account?

  • Office

    840 Walnut St
    Ste 1440
    Philadelphia, PA 19107
    Phone+1 215-928-3105
    Fax+1 215-928-1140

Education & Training

  • Sidney Kimmel Medical College at Thomas Jefferson University/TJUH
    Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 1988 - 1989
  • Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye Hospital
    Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1984 - 1988
  • Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye Hospital
    Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1984 - 1987
  • UPMC Medical Education (Mercy)
    UPMC Medical Education (Mercy)Internship, Transitional Year, 1983 - 1984
  • University of Pittsburgh School of Medicine
    University of Pittsburgh School of MedicineClass of 1983

Certifications & Licensure

  • DC State Medical License
    DC State Medical License Current
  • DE State Medical License
    DE State Medical License Current
  • NY State Medical License
    NY State Medical License 1995 - 2026
  • NJ State Medical License
    NJ State Medical License 1985 - 2025
  • PA State Medical License
    PA State Medical License 1984 - 2024
  • MD State Medical License
    MD State Medical License 2018 - 2023
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2007-2014
  • Philadelphia Magazine Castle Connolly, 2005-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Visual Outcome and Millimeter Incremental Risk of Metastasis in 1780 Patients with Small Choroidal Melanoma Managed by Plaque Radiotherapy  
    Lydia Komarnicky, Arman Mashayekhi, Carol L Shields, Laura E Barna, Jerry A Shields, JAMA
  • Comparison of Posterior Lamellar Resection Versus Lumpectomy for Initial Management of Localized Tarsal Conjunctival Sebaceous Carcinoma in 54 Cases  
    Jerry A Shields, Carol L Shields, Sara E Lally, Indian Journal of Ophthalmology

Lectures

  • Detection of Retinoblastoma at Risk for Metastasis Using Clinical and Histopathologic Features and Now mRNA 
    Wills Eye Institute, Philadelphia, Pennsylvania - 4/22/2013
  • Sudden Ocular Pain from Underlying Mass 
    Emory University School of Medicine, Atlanta, Georgia - 9/28/2012

Press Mentions

  • Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye Cancer
    Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye CancerOctober 21st, 2024
  • IDEAYA Biosciences Announces Positive Interim Phase 2 Data for Darovasertib and Successful FDA Type C Meeting on Registrational Trial Design for Regulatory Approval in Neoadjuvant Uveal Melanoma
    IDEAYA Biosciences Announces Positive Interim Phase 2 Data for Darovasertib and Successful FDA Type C Meeting on Registrational Trial Design for Regulatory Approval in Neoadjuvant Uveal MelanomaSeptember 23rd, 2024
  • IDEAYA Announces Darovasertib Phase 2 Initiation in Neoadjuvant and Adjuvant Uveal Melanoma and Guidance for Clinical Data Update in Metastatic Uveal Melanoma
    IDEAYA Announces Darovasertib Phase 2 Initiation in Neoadjuvant and Adjuvant Uveal Melanoma and Guidance for Clinical Data Update in Metastatic Uveal MelanomaJanuary 23rd, 2023
  • Join now to see all

Professional Memberships